ArticleFrontiers in endocrinology2024

Response: Commentary: Azathioprine as an adjuvant therapy in severe Graves' disease: a randomized controlled open-label clinical trial.

Magdy Mohamed Allam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.